Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimicrobial Efficacy of ALT005 Ophthalmic Prep Solution
NCT01531699Phase 3Completed
- Sponsor
- Altacor
- Start
- Feb 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ALT-005 in surgical site infection (SSI), sponsored by Altacor. Started Feb 2012; status: completed.
02
Drugs
ALT-005
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT01531699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01531699.